Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.
about
Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesicsOpioid receptor trafficking and interaction in nociceptorsAntibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and functionOpioid receptor heteromers in analgesiaKnockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo.Dual efficacy of delta opioid receptor-selective ligands for ethanol drinking and anxietyProtein kinase C mediates the synergistic interaction between agonists acting at alpha2-adrenergic and delta-opioid receptors in spinal cord.Synaptic mechanism for functional synergism between delta- and mu-opioid receptors.In search of analgesia: emerging roles of GPCRs in pain.Short term morphine exposure in vitro alters proliferation and differentiation of neural progenitor cells and promotes apoptosis via mu receptors.Opioid-receptor-heteromer-specific trafficking and pharmacology.Modulation of delta opioid agonist-induced antinociception by repeated morphine pretreatment in rhesus monkeys.Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons.How to design an opioid drug that causes reduced tolerance and dependence.The delta opioid receptor antagonist, SoRI-9409, decreases yohimbine stress-induced reinstatement of ethanol-seeking.Alterations of CXCR4 function in μ-opioid receptor-deficient glia.Dissociation of μ- and δ-opioid inhibition of glutamatergic synaptic transmission in superficial dorsal horn.Investigational pharmacology for low back pain.Tissue injury regulates serotonin 1D receptor expression: implications for the control of migraine and inflammatory painHormonal regulation of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus.Opioid-induced down-regulation of RGS4: role of ubiquitination and implications for receptor cross-talk.Arthritis and pain. Future targets to control osteoarthritis painOpioid pharmaceuticals and addiction: the issues, and research directions seeking solutions.Analgesic synergy between opioid and α2 -adrenoceptorsRecent advances on the δ opioid receptor: from trafficking to function.In vivo opioid receptor heteromerization: where do we stand?Prolonged morphine treatment alters δ opioid receptor post-internalization traffickingLigand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors.Dissociation of the opioid receptor mechanisms that control mechanical and heat painOvarian hormones influence corticotropin releasing factor receptor colocalization with delta opioid receptors in CA1 pyramidal cell dendrites.Escorts take the lead molecular chaperones as therapeutic targetsAntinociceptive activity of methanolic extract of Muntingia calabura leaves: further elucidation of the possible mechanismsImplication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.Development and in vitro characterization of a novel bifunctional μ-agonist/δ-antagonist opioid tetrapeptide.Chronic methadone treatment shows a better cost/benefit ratio than chronic morphine in mice.Primary afferent neurons express functional delta opioid receptors in inflamed skin.Pleiotropic opioid regulation of spinal endomorphin 2 release and its adaptations to opioid withdrawal are sexually dimorphic.Distinctive modulation of ethanol place preference by delta opioid receptor-selective agonists.Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibitionDual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.
P2860
Q24647687-650A1965-97BD-4E4D-BF98-2D794788F5D3Q26822251-0955CBDE-95A9-46F8-AAC5-16287A4C997EQ26992192-4A78CE35-F4DE-4755-9E97-EAB9691F6250Q27004306-6055F4E2-07F5-4D4D-831E-E24BACD19913Q30477441-5D01E088-B549-4475-A638-6064F4D2C3F4Q30497060-BECF5468-0C0C-4200-85EB-687104A61220Q33643934-CC4BAF51-A4F7-4367-9967-F62F383F7962Q33806664-18AA39C9-5D7A-4206-9C2F-8F4DB41DC03EQ33819256-6BB454DB-8FDE-467E-BD25-6741128FBEEFQ33968232-150AEC8A-144D-4525-9B51-3B932790EA56Q33978499-5620128F-CCA5-44F4-A32C-DEE965214731Q34033904-AEA4844B-27FB-493F-9879-AB20EE66D6EBQ34059144-3D89C54E-9E9B-470A-9DB0-FB9C34E42986Q34144947-0659E84B-DEB4-4187-A4B5-D40336B07FC2Q34163725-4BC1A3A7-F406-4652-864E-6D9549C27CE4Q34209473-3CEE4413-0766-4121-95FE-0BFC5D7EFD4BQ34331998-E580F8E7-90D9-49DB-8D91-66C1EE4DB753Q34418362-DC02B4C8-BA76-4695-AEDC-B92581E8B048Q34555809-B616C00C-CA95-4CF7-9739-190712D75B67Q34609538-86EFC1DB-5A90-4D03-BBD3-C0FE9A42E1F2Q34624142-E303974E-2B99-4CC9-A361-2995050DB7B7Q34636446-BB8DB836-FB26-4385-A4FF-FDBA47DFED2AQ34773536-2DD0719B-77FC-48CA-B2BC-9695F0D2261CQ34939644-3C4B3D14-4972-4B2E-AAB5-A575304D4BFEQ34939664-F09709E3-48F3-4C55-98D8-78FB76CD8585Q34939677-1B1038DA-5B10-41ED-A1A5-5827B11BEDEAQ34939888-285FC218-84C3-4364-97C4-D1314158DDBFQ34939914-44819964-B131-4DD7-A760-B2F26C2C6DEEQ34986633-FCF5D57F-6A84-4F74-A6A9-81193BC7F3C2Q35042628-D5215694-EA34-4609-B86E-D198E859EAEDQ35075365-7D4B352C-4001-418E-A553-90F10E2ECCA2Q35098782-0258C17C-0650-4C7B-8279-465AB4F3F4BBQ35327954-1F37E35C-ECBB-4E84-8048-DBF19BCF53E9Q35621534-930E9174-C16B-4273-B3A0-8E11F0BFA91DQ35688547-C0905935-1FE7-462A-89BD-A297FF524F02Q35688873-17FFF980-4EAD-4931-B513-0C6B76E20B7EQ35721875-7A3BA3D2-6192-4BA0-B5F6-1C1C77B02B37Q35757407-6B808F03-92D0-458F-B3D6-DCD63C80CA98Q36155156-4BDCBC8A-D2C7-4238-BB75-0B6D41866FCBQ36304961-831A240E-6485-4144-B85D-64B979EAB86B
P2860
Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Prolonged morphine treatment t ...... elta-mediated antinociception.
@en
Prolonged morphine treatment t ...... elta-mediated antinociception.
@nl
type
label
Prolonged morphine treatment t ...... elta-mediated antinociception.
@en
Prolonged morphine treatment t ...... elta-mediated antinociception.
@nl
prefLabel
Prolonged morphine treatment t ...... elta-mediated antinociception.
@en
Prolonged morphine treatment t ...... elta-mediated antinociception.
@nl
P2093
P1476
Prolonged morphine treatment t ...... delta-mediated antinociception
@en
P2093
P304
P356
10.1523/JNEUROSCI.21-19-07598.2001
P407
P577
2001-10-01T00:00:00Z